Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin vs HES vs Ringer Lactate for Volume Replacement in Cardiac Surgery
NCT01174719Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Mar 2006
- Primary completion
- Feb 2010
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hetastarch in valvular heart disease (VHD) and coronary artery disease (CAD), sponsored by Medical University of Vienna. Primary endpoint: Chest tube drainage at 24 hours. Started Mar 2006; status: completed.
02
Drugs
hetastarch
03
Conditions
valvular heart disease (VHD)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01174719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01174719.